(333) TRENDS IN PHOSPHODIESTERASE TYPE 5 INHIBITOR PRESCRIPTIONS AND COST: MEDICARE ANALYSIS 2017-2021
Cahill E, Reddy S, Rotker K, Honig S. (333) TRENDS IN PHOSPHODIESTERASE TYPE 5 INHIBITOR PRESCRIPTIONS AND COST: MEDICARE ANALYSIS 2017-2021. The Journal Of Sexual Medicine 2024, 21: qdae167.321. DOI: 10.1093/jsxmed/qdae167.321.Peer-Reviewed Original ResearchPhosphodiesterase type 5Non-urologistsPDE5 inhibitorsPhosphodiesterase type 5 inhibitorsMedicare Part D databaseMedicare Part D Public Use FilesCompared urologistsPrescribed tadalafilPrescribed sildenafilSildenafil prescriptionsCost of medicationsErectile dysfunctionInhibitor medicationPrescribing patternsUrologistsPatient comfortPrimary care providersSildenafilTadalafilType 5